Viewing Study NCT04408118


Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2026-03-15 @ 8:56 PM
Study NCT ID: NCT04408118
Status: COMPLETED
Last Update Posted: 2024-06-04
First Post: 2020-05-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: First Line Atezolizumab, Paclitaxel, and Bevacizumab (AvastinĀ®) in mTNBC
Sponsor: MedSIR
Organization: